+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients



Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients



Journal of the American Society of Nephrology 7(2): 325-330



Recent studies showed contradictory results concerning the efficacy of oral acyclovir in the prevention or amelioration of cytomegalovirus (CMV) disease after renal transplantation (TX).

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008826156

Download citation: RISBibTeXText

PMID: 8785404


Related references

Acyclovir prophylaxis for cytomegalovirus disease in high-risk renal transplant recipients: is it effective?. Kidney International. Supplement 57: S62-S65, 1996

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients. Antimicrobial Agents and ChemoTherapy 35(5): 938-943, 1991

High dose oral acyclovir does not prevent CMV disease in high-risk renal transplant recipients. Nephrology Dialysis Transplantation 10(6): 1067, 1995

Cytomegalovirus infection in renal transplant recipients on prophylaxis with high-dose acyclovir. Nephrology Dialysis Transplantation 7(7): 782, 1992

Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients. PharmacoTherapy 2018:, 2018

Long-term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalovirus high-risk renal transplant recipients. Transplantation 70(8): 1174-1180, 2000

Prevention of cytomegalovirus disease in renal transplant recipients using cytomegalovirus immune globulin and high dose acyclovir. Journal of Urology 149(4 Suppl. ): 391A, 1993

High dose oral acyclovir acv prophylaxis for primary cytomegalovirus cmv infection in seronegative renal allograft recipients. Pharmacotherapy 11(3): 277, 1991

High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipients. Transplantation 55(2): 448-450, 1993

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Transplantation 66(12): 1682-1688, 1998

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 58(7): 779-785, 1994

High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients. Annals of PharmacoTherapy 52(1): 5, 2018

Studies evaluating high-dose acyclovir, intravenous immune globulin, and cytomegalovirus hyperimmunoglobulin for prophylaxis against cytomegalovirus in kidney transplant recipients. Annals of PharmacoTherapy 30(12): 1452-1464, 1996

Questionable benefit of prophylactic acyclovir on cytomegalovirus disease in high risk renal transplant recipients. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 348, 1992

Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits. Transplantation Proceedings 30(5): 2094, 1998